Ophthalmia Neonatorum
Neonatal Conjunctivitis: Causes, Diagnosis & Management
Examination question · ~800 words
Define ophthalmia neonatorum. Discuss its etiology, clinical features, investigations, management, complications, and prophylaxis.
Try to outline your answer mentally before expanding sections below.
Ophthalmia neonatorum (ON) is conjunctival inflammation occurring within the first 28 days of life. It ranges from benign chemical conjunctivitis to sight-threatening and life-threatening infections such as gonococcal ophthalmia and neonatal herpes. It is a paediatric ophthalmic emergency because untreated gonococcal ON can cause corneal ulceration and perforation within 24–48 hours. Rapid etiological diagnosis, systemic therapy where indicated, maternal-partner treatment, and neonatal prophylaxis are central to preventing blindness.
Ophthalmia neonatorum is any conjunctivitis presenting in the first 4 weeks of life. Etiology varies with antenatal screening, intrapartum exposure, prophylaxis practices, and NICU infection control.
| Cause | Organism / Agent | Typical Onset | Key Point |
|---|---|---|---|
| Chemical | Silver nitrate or topical prophylactic agent reaction | Within 24 h | Self-limiting, non-infective |
| Chlamydial | Chlamydia trachomatis serovars D–K | 5–14 days | Common in developed settings; systemic treatment required |
| Gonococcal | Neisseria gonorrhoeae | 2–5 days | Most urgent; profuse pus and corneal melt risk |
| Staphylococcal | S. aureus, S. epidermidis | 4–14 days | Common, usually milder |
| Haemophilus | H. influenzae, H. aegyptius | 4–21 days | Moderate severity |
| Herpetic | Usually neonatal HSV-2 | 5–14 days | Rare but sight- and life-threatening |
| Other bacterial | S. pneumoniae, GBS, Pseudomonas, enteric Gram-negative rods | Variable | NICU-acquired organisms may be severe |
In India, S. aureus and C. trachomatis predominate, but gonococcal ON remains the highest-urgency diagnosis because of rapid corneal perforation risk.
Routes of Transmission
- Perinatal / intrapartum transmission is the commonest route: exposure to infected cervicovaginal secretions during delivery, especially for N. gonorrhoeae, C. trachomatis, and HSV-2.
- Postnatal transmission occurs via caregiver hands, contaminated instruments, droplets, or NICU environmental sources; organisms include S. aureus, Pseudomonas, and enteric Gram-negative rods.
- Chemical ON is a toxic reaction to topical prophylaxis, classically silver nitrate, and is not infective.
- Antenatal transmission is less common and may occur with ascending infection, prolonged rupture of membranes, or invasive intrauterine procedures.
Organism-Specific Mechanisms
| Organism | Pathogenesis |
|---|---|
| N. gonorrhoeae | Pili mediate adherence; LOS endotoxin and IgA protease trigger intense PMN inflammation. Organism- and PMN-derived collagenases cause corneal melt. |
| C. trachomatis | Elementary bodies infect conjunctival epithelium; reticulate bodies multiply intracellularly and cause cell lysis. Neonates show papillary reaction rather than follicles because conjunctival lymphoid tissue is immature. |
| HSV | Usually vertically transmitted HSV-2; conjunctivitis may accompany or precede disseminated or CNS neonatal herpes. |
Timing of onset is the most useful initial clinical differentiator, but treatment of suspected gonococcal or herpetic disease must not wait for culture confirmation.
| Feature | Chemical | Gonococcal | Chlamydial | Staphylococcal | Herpetic |
|---|---|---|---|---|---|
| Onset | <24 h | 2–5 days | 5–14 days | 4–14 days | 5–14 days |
| Discharge | Watery / mild mucopurulent | Profuse hyperpurulent | Mucopurulent | Mucopurulent | Watery / serosanguinous |
| Lid oedema | + | +++ | ++ | + | + |
| Conjunctiva | Mild injection | Beefy red, tense conjunctiva | Papillary reaction | Mild-moderate injection | Follicular/vesicular association may occur |
| Cornea | None | Ulceration / perforation | Micropannus late | Usually mild | Dendritic / stromal keratitis |
| Systemic association | None | Sepsis, arthritis, meningitis | Pneumonitis, rhinitis, otitis | Rare sepsis | Encephalitis, sepsis, disseminated HSV |
| Laterality | Usually bilateral | Usually bilateral | Often bilateral | Usually bilateral | Unilateral common |
- The classic gonococcal picture is severe lid oedema, tense conjunctiva, and profuse purulent discharge.
- Chlamydial ON requires systemic treatment because nasopharyngeal colonisation can lead to pneumonitis at 4–12 weeks.
- ON with skin vesicles, seizures, lethargy, or sepsis signs should be treated as neonatal HSV until proven otherwise.
Sampling Technique
- Take conjunctival scraping or swab from the lower fornix, not the lid margin.
- For suspected gonococcus, inoculate immediately onto appropriate media and request antimicrobial sensitivity.
- Use bacterial transport medium such as Amies for bacteria; use viral transport medium or HSV PCR swab if vesicles or keratitis suggest HSV.
- Screen mother and partner for STIs and arrange contact tracing.
| Investigation | Purpose | Expected Finding / Role |
|---|---|---|
| Gram stain | Immediate triage for gonococcal and bacterial ON | Intracellular Gram-negative diplococci are highly suggestive of gonococcal ON; Gram-positive cocci suggest staphylococcal disease |
| Giemsa stain | Chlamydial cytology | Basophilic intracytoplasmic inclusions in epithelial cells |
| Culture: blood / chocolate agar | Gonococcal isolation and sensitivity | Oxidase-positive organism fermenting glucose only; culture is needed for antibiotic sensitivity |
| Culture: McCoy cells / HeLa 229 | Chlamydial culture | Historical gold standard, now superseded by NAAT/PCR for routine diagnosis; useful where NAAT is unavailable or for research |
| NAAT / PCR | C. trachomatis, N. gonorrhoeae, HSV | Current routine gold-standard approach for chlamydial ON; highest sensitivity and specificity |
| Direct immunofluorescence | Chlamydial antigen detection | Rapid test, lower sensitivity than NAAT |
| HSV PCR / viral culture | Herpetic ON | Mandatory when vesicles, keratitis, or systemic herpes features are present |
| Blood culture and lumbar puncture | Systemic sepsis / meningitis evaluation | Indicated in systemically unwell neonates, suspected disseminated gonococcus, or neonatal HSV |
| Maternal STI screen | Source control and contact tracing | GC/Chlamydia NAAT, VDRL, HIV and other STI testing as appropriate |
General Principles
- Treat suspected gonococcal ON and herpetic ON as emergencies.
- Isolate neonate where gonococcal or herpetic infection is suspected.
- Use frequent sterile saline lavage to remove discharge, especially in gonococcal ON.
- Notify paediatrics for systemic evaluation and treatment.
- Treat mother and sexual partner simultaneously in gonococcal and chlamydial disease.
| Etiology | Ocular Treatment | Systemic Treatment | Duration / Note |
|---|---|---|---|
| Chemical | Lubricants | None | Resolves within 24–48 h |
| Gonococcal | Hourly saline lavage; topical antibiotic only as adjunct; add intensive topical fluoroquinolone if cornea involved | Ceftriaxone 25–50 mg/kg IM/IV single dose, maximum 125 mg in Indian PYQ/IAP India context | Immediate treatment; corneal perforation risk within 24–48 h if untreated |
| Chlamydial | Erythromycin or tetracycline ointment as adjunct only | Erythromycin ethylsuccinate 50 mg/kg/day orally in 4 divided doses for 14 days; azithromycin 20 mg/kg once daily for 3 days is an alternative increasingly used | Systemic therapy is mandatory to eradicate nasopharyngeal reservoir and prevent pneumonitis |
| Herpetic | Acyclovir 3% ointment 5 times/day or ganciclovir 0.15% gel | IV acyclovir 60 mg/kg/day in 3 divided doses | 14 days for isolated disease; 21 days for CNS/disseminated disease |
| Staphylococcal | Topical chloramphenicol 0.5% or fusidic acid | Usually not required | 7–10 days |
| H. influenzae | Topical chloramphenicol | Consider amoxicillin-clavulanate if severe | Based on severity |
| Pseudomonas / NICU Gram-negative | Topical tobramycin or fortified antipseudomonal therapy | Systemic antipseudomonal therapy such as ceftazidime or piperacillin-tazobactam as guided by paediatrics/culture | High corneal melt risk; urgent ophthalmology review |
For Indian PYQ/NNF/IAP-style answers, neonatal gonococcal ON is treated with ceftriaxone 25–50 mg/kg IM/IV single dose, maximum 125 mg. Do not cite WHO 2016 as the basis for the 125 mg ceiling: WHO gives a different maximum, and CDC 2021 uses a higher US-specific ceiling.
Oral erythromycin in neonates younger than 6 weeks is associated with infantile hypertrophic pyloric stenosis risk; counsel parents and monitor. Azithromycin is increasingly preferred in many centres.
Credé prophylaxis was introduced by Carl Credé in 1881 using 1% silver nitrate instillation at birth, dramatically reducing gonococcal ophthalmia. Silver nitrate is now largely abandoned because it commonly causes chemical conjunctivitis and does not protect against chlamydial ON.
| Agent | Coverage | Chemical Irritation | Current Status |
|---|---|---|---|
| Silver nitrate 1% | Gonococcus only | High; chemical ON common | Historical; largely abandoned |
| Tetracycline 1% ointment | GC + partial Chlamydia | Mild | WHO-supported option in resource-limited settings |
| Erythromycin 0.5% ointment | GC + partial Chlamydia | Minimal | Standard prophylaxis in the USA |
| Povidone-iodine 2.5% | GC + Chlamydia + HSV | Minimal | Broad-spectrum, inexpensive, increasingly used |
| Azithromycin 1% drops | GC + Chlamydia | Minimal | Promising; under evaluation |
| No prophylaxis | None | None | Used in some countries with robust antenatal screening |
Povidone-iodine 2.5% is the broadest-spectrum prophylactic agent listed here, with activity against N. gonorrhoeae, C. trachomatis, and HSV. In the landmark Isenberg et al. 1995 trial, it was more effective against chlamydial prevention than erythromycin or silver nitrate.
Ocular Complications
- Corneal ulceration, melting, perforation and endophthalmitis, especially in gonococcal ON
- Corneal scarring leading to amblyopia or permanent visual loss
- Late pannus formation in chlamydial disease
- Symblepharon in severe chemical or gonococcal conjunctivitis
- Herpetic keratitis, anterior uveitis, secondary glaucoma, retinitis or optic neuritis
Systemic Complications
- Gonococcal: septicaemia, meningitis, arthritis, scalp abscess
- Chlamydial: pneumonitis at 4–12 weeks, rhinitis, otitis media
- Herpetic: encephalitis, hepatitis, disseminated HSV with high mortality if untreated
Ophthalmia neonatorum is a preventable cause of neonatal ocular morbidity. Examination must rapidly identify high-risk patterns: day 2–5 profuse purulence suggests gonococcus, day 5–14 mucopurulence suggests chlamydia, and vesicles or systemic illness suggest HSV. Gram stain, NAAT/PCR, and culture guide diagnosis, but emergency systemic therapy must not be delayed in gonococcal or herpetic disease. Effective birth prophylaxis and antenatal STI screening remain the best public health strategies.
Trap 1 — FALSE
“Topical erythromycin alone is adequate treatment for chlamydial ophthalmia neonatorum.”
Systemic treatment is mandatory because topical therapy does not eradicate the nasopharyngeal reservoir or prevent chlamydial pneumonitis.
Trap 2 — FALSE
“Follicles are prominent in neonatal chlamydial conjunctivitis.”
Follicles are absent or poorly formed in neonates because conjunctival lymphoid tissue is immature; a papillary reaction is expected instead.
Trap 3 — FALSE
“Silver nitrate prophylaxis protects against chlamydial ophthalmia neonatorum.”
Silver nitrate protects mainly against gonococcal ON and does not prevent chlamydial disease.
Trap 4 — TRUE
“Credé prophylaxis classically used 1% silver nitrate.”
Carl Credé introduced 1% silver nitrate instillation at birth; higher-strength early formulations were abandoned because of severe chemical conjunctivitis.
Trap 5 — FALSE
“A neonate with profuse purulent discharge on day 2 should wait for culture before treatment.”
Suspected gonococcal ON requires immediate Gram stain, systemic ceftriaxone, and saline lavage; treatment must not wait for culture.
Trap 6 — TRUE
“Povidone-iodine 2.5% is the broadest-spectrum prophylactic option among the listed agents.”
It has activity against gonococcus, chlamydia, and HSV, with low cost and minimal chemical toxicity.
Trap 7 — FALSE
“Chlamydial cell culture remains the routine diagnostic gold standard.”
Cell culture on McCoy cells or HeLa 229 was the historical gold standard; NAAT/PCR has superseded it for routine diagnosis.
Q: What is ophthalmia neonatorum?
A: Any conjunctival inflammation occurring within the first 28 days of life.
Q: What is the most important clinical differentiator in ON?
A: Timing of onset: chemical <24 h, gonococcal 2–5 days, chlamydial 5–14 days.
Q: What finding suggests gonococcal ON?
A: Profuse hyperpurulent discharge with severe lid oedema and beefy red conjunctiva.
Q: Why is gonococcal ON an emergency?
A: It can cause corneal ulceration, melting, and perforation within 24–48 hours if untreated.
Q: Drug of choice for gonococcal ON in Indian PYQ context?
A: Ceftriaxone 25–50 mg/kg IM/IV single dose, maximum 125 mg.
Q: Why must chlamydial ON be treated systemically?
A: To eradicate the nasopharyngeal reservoir and prevent chlamydial pneumonitis.
Q: What does neonatal ON with skin vesicles suggest?
A: Neonatal HSV; start IV acyclovir and evaluate for CNS/disseminated disease.
Q: What is the broadest-spectrum prophylactic agent for ON?
A: Povidone-iodine 2.5%, covering gonococcus, chlamydia, and HSV.
A premature neonate born at 28 weeks in the NICU develops hyperacute purulent conjunctivitis on day 10 of life. Gram stain reveals Gram-negative diplococci. The mother had routine antenatal care with a negative gonococcal screen at 36 weeks. How do you reconcile this epidemiology, how does management differ from a term neonate with gonococcal ON, and what are the NICU implications?
Answer
Day-10 gonococcal ON in a premature NICU neonate raises concern for a false-negative antenatal screen, maternal acquisition after screening, inadequate birth prophylaxis, or horizontal NICU transmission via contaminated hands, instruments, or surfaces. Treat as a critical ophthalmic and infection-control emergency. Give weight-adjusted systemic cephalosporin therapy; ceftriaxone requires caution in premature neonates with hyperbilirubinaemia because it can displace bilirubin from albumin, so cefotaxime is preferred if jaundice is present. Perform urgent ophthalmology review, frequent saline lavage, corneal assessment, blood culture, and lumbar puncture to exclude dissemination. Isolate the neonate, notify infection control, institute cohort nursing, swab exposed neonates if indicated, re-screen mother and partner, audit prophylaxis records, and review NICU decontamination protocols. A single NICU case is a sentinel event requiring root-cause analysis.
References
- Kanski JJ, Bowling B. Clinical Ophthalmology: A Systematic Approach. 8th ed. Elsevier; 2016.
- Yanoff M, Duker JS. Ophthalmology. 5th ed. Elsevier; 2023.
- Taylor D, Hoyt CS. Paediatric Ophthalmology and Strabismus. 4th ed. Saunders; 2012.
- AAO Basic and Clinical Science Course. Pediatric Ophthalmology and Strabismus; External Disease and Cornea.
- IAP India Standard Treatment Guidelines 2022: Ophthalmia Neonatorum.
- WHO Guidelines for the Treatment of Neisseria gonorrhoeae. 2016.
- Hammerschlag MR, Kohlhoff SA. Treatment of chlamydial conjunctivitis. Expert Review of Anti-infective Therapy. 2012;10(4):441-448.
- Isenberg SJ et al. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. New England Journal of Medicine. 1995;332(9):562-566.
- Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.